medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2019, Number S1

<< Back Next >>

Acta Med 2019; 17 (S1)

Cryopreservation of gametes and embryos, to who, when and how?

Olavarría GMY, Roque SAM

Language: Spanish
References: 27
Page: 54-61
PDF size: 148.81 Kb.


ABSTRACT

The preservation of fertility is an emerging field of gynecology, that is rapidly growing for the positive results it has achieved, in a short time. It consists of the application of medical, surgical and laboratory techniques to preserve the reproductive potential of both men and women. Initially planned for patients whose fertility was at risk from oncological treatments, it had had a boom in women who wanted to delay the biological clock of motherhood. Innovations such as vitrification of ovarian tissue are currently considered part of the palette of options, with a view to new technologies such as artificial ovary and sperm maturation in vitro are still in experimentation. The knowledge of the health professional of these techniques will allow patients to have access to them, prior to their treatment they can go to reproductive specialist and evaluate the alternatives according to their case for the conservation of their reproductive potential.


REFERENCES

  1. Gook DA, Edgar DH. Cryopreservation of female reproductive potential. Best Pract Res Clin Obstet Gynaecol. 2019; 55: 23-36.

  2. Martinez F, International Society for Fertility Preservation-ESHRE-ASRM Expert Working Group. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives. Fertil Steril. 2017; 108 (3): 407-415.

  3. Donnez J, Dolmas M. Fertility preservation in women. N Engl J Med. 2017; 377 (17): 1657-1665.

  4. Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018; 36 (19): 1994-2001.

  5. Grynberg M, Raad J, Comtet M, Vinolas C, Cédrin-Durnerin I, Sonigo C. Fertility preservation in BRCA-mutated women: when and how? Future Oncol. 2018; 14 (5): 483-490.

  6. Cárdenas SJ, Bargalló RE, Erazo VA, Maafs ME, Poitevin CA. Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Quinta revisión. Colima, Masson Doyma. 2013.

  7. Han W, Kang SY, Korean Breast Cancer Society. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat. 2001; 119 (1): 193-200.

  8. Schüring AN, Fehm T, Behringer K, Goeckenjan M, Wimberger P, Henes M et al. Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Arch Gynecol Obstet. 2018; 297 (1): 241-255.

  9. Zapardiel I, Cruz M, Diestro MD, Requena A, Garcia-Velasco JA. Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers. Hum Reprod Update. 2016; 22 (3): 281-305.

  10. Peccatori FA, Mangili G, Bergamini A, Filippi F, Martinelli F, Ferrari F et al. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? Hum Reprod. 2018; 33 (2): 181-187.

  11. Abram McBride J, Lipshultz LI. Male fertility preservation. Curr Urol Rep. 2018; 19 (7): 49.

  12. Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline. Lancet. 2014; 384 (9950): 1311-1319.

  13. Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility reservation. Fertil Steril. 2016; 105 (3): 755-764. e8.

  14. Soriano-Ortega KP, Carballo-Mondragón E, Roque-Sánchez AM, Durán-Monterrosas L, Kably-Ambe A. Percepción de fertilidad de mujeres en edad repro- ductiva de acuerdo a su edad. Ginecol Obstet Mex. 2017; 85 (6): 364-373.

  15. Yurchuk T. Science of cryopreservation in reproductive medicine - Embryos and oocytes as exemplars. Early Hum Dev. 2018; 126: 6-9.

  16. Levi Setti PE, Porcu E, Patrizio P, Vigiliano V, de Luca R, d’Aloja P et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007-2011. Fertil Steril. 2014; 102 (1): 90-95. e2.

  17. Sighinolfi G, Sunkara S, La Marca A. New strategies of ovarian stimulation based on the concept of ovarian follicular waves: from conventional to random and double stimulation. Reprod Biomed Online. 2018; 37 (4): 489-497.

  18. Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online. 2010; 20 (5): 634-638.

  19. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril. 2013; 99 (3): 663-666.

  20. Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013; 9 (12): 735-749.

  21. Kim SY, Kim SK, Lee JR, Woodruff TK. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women. J Gynecol Oncol. 2016; 27 (2): e22.

  22. Dolmans MM, Marotta ML, Pirard C, Donnez J, Donnez O. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res. 2014; 7: 80.

  23. Diaz-Garcia C, Domingo J, Garcia-Velasco JA, Herraiz S, Mirabet V, Iniesta I et al. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study. Fertil Steril. 2018; 109 (3): 478-485.e2.

  24. Gies I, Oates R, De Schepper J, Tournaye H. Testicular biopsy and cryopreservation for fertility preservation of prepubertal boys with Klinefelter syndrome: a pro/con debate. Fertil Steril. 2016; 105 (2): 249-255.

  25. Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013; 110 (43): 17474-17479.

  26. Wallace WH, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014; 15 (10): 1129-1136.

  27. Jensen AK, Rechnitzer C, Macklon KT, Ifversen MR, Birkebæk N, Clausen N et al. Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development. Hum Reprod. 2017; 32 (1): 154-164.




2020     |     www.medigraphic.com